We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.74%
2 Financials 9%
3 Healthcare 8.22%
4 Consumer Discretionary 6.53%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYLD icon
3626
Cambria Shareholder Yield ETF
SYLD
$1.03B
$209K ﹤0.01%
+3,468
New +$214K
GPP
3627
DELISTED
Green Plains Partners LP
GPP
$209K ﹤0.01%
15,764
-3,531
-18% -$45.4K
POWA icon
3628
Invesco Bloomberg Pricing Power ETF
POWA
$183M
$208K ﹤0.01%
+3,143
New +$214K
PXH icon
3629
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
$208K ﹤0.01%
+9,331
New +$212K
BOKF icon
3630
BOK Financial
BOKF
$8.83B
$207K ﹤0.01%
2,306
-390
-14% -$33.4K
SXT icon
3631
Sensient Technologies
SXT
$5.56B
$207K ﹤0.01%
+2,272
New +$199K
AUD
3632
DELISTED
Audacy, Inc.
AUD
$207K ﹤0.01%
56,219
-110
-0.2% -$385
WEBR
3633
DELISTED
Weber Inc.
WEBR
$207K ﹤0.01%
+11,747
New +$188K
CALX icon
3634
Calix
CALX
$2.54B
$206K ﹤0.01%
+4,167
New +$192K
NWG icon
3635
NatWest
NWG
$76.9B
$206K ﹤0.01%
31,471
+1,591
+5% +$9.9K
ONEM
3636
DELISTED
1Life Healthcare
ONEM
$206K ﹤0.01%
10,155
-20,684
-67% -$532K
EGHT icon
3637
8x8 Inc
EGHT
$298M
$205K ﹤0.01%
8,752
-20
-0.2% -$501
HEQ
3638
John Hancock Hedged Equity & Income Fund
HEQ
$141M
$205K ﹤0.01%
16,308
+791
+5% +$10.5K
WEA
3639
Western Asset Premier Bond Fund
WEA
$125M
$205K ﹤0.01%
14,547
+1,985
+16% +$29K
DVYE icon
3640
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
$204K ﹤0.01%
5,244
-287
-5% -$11.1K
GGT
3641
Gabelli Multimedia Trust
GGT
$176M
$204K ﹤0.01%
+22,638
New +$216K
UWMC icon
3642
UWM Holdings
UWMC
$2.61B
$204K ﹤0.01%
29,287
-6,925
-19% -$51.6K
ALX
3643
Alexander's
ALX
$1.4B
$203K ﹤0.01%
778
-111
-12% -$29.7K
GURU icon
3644
Global X Guru Index ETF
GURU
$64.3M
$203K ﹤0.01%
4,170
-121
-3% -$5.95K
IOVA icon
3645
Iovance Biotherapeutics
IOVA
$2.97B
$203K ﹤0.01%
8,239
-8,726
-51% -$206K
QEFA icon
3646
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.08B
$203K ﹤0.01%
2,705
TFSL icon
3647
TFS Financial
TFSL
$4.93B
$203K ﹤0.01%
10,637
-342
-3% -$6.67K
XHR
3648
Xenia Hotels & Resorts
XHR
$1.76B
$203K ﹤0.01%
11,439
-672
-6% -$11.8K
UCB
3649
United Community Banks
UCB
$4.41B
$203K ﹤0.01%
+6,186
New +$185K
SRLP
3650
DELISTED
SPRAGUE RESOURCES LP
SRLP
$203K ﹤0.01%
10,890
-1,250
-10% -$26.6K

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.